Quadrise shares sank on Thursday after the company said emulsion fuel and biofuel trials in Morocco are facing more delays due to mechanical problems at the project.
Quadrise shares were down 32% at the time of writing.
Hopes of successful fuel testing were dashed as Quadrise encountered further setbacks with its ongoing trial in Morocco. After returning to the site to restart testing, the company managed to achieve combustion at full load. However, fuel pumps began to decline in performance, preventing full load testing.
The problems continued as a replacement pump exhibited similar issues when operating at high pressure, indicating a fundamental design flaw. The trial is now expected to finish in September as opposed to June.
While certainly disappointing given the previous setbacks, Quadrise remains committed to resolving the pump problem and completing the trial. The company is working quickly to ship an alternative pump design to overcome this latest hurdle.
Despite the delays and difficulties, Quadrise still aims to persevere and successfully finish testing.
Jason Miles, CEO of Quadrise commented:
“The design issues experienced with the pumps to date were not foreseeable and are very frustrating for all concerned. We remain highly confident that once the trial resumes following the installation of an alternative pump, we will be able to demonstrate the benefits of MSAR® and bioMSAR™ in the commercial trial for our supportive client.”
